This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Stearns, M. Articles by Sell, C. Search for Related Content PubMed PubMed Citation Articles by Stearns, M. Articles by Sell, C.

Activated Ras Enhances Insulin-Like Growth Factor I Induction of Vascular Endothelial Growth Factor in Prostate Epithelial Cells

¹ Department of Pathology, Drexel University School of Medicine; ² Wistar Institute, Philadelphia, Pennsylvania; ³ Department of Biology, Villanova University, Villanova, Pennsylvania; and ⁴ Lankenau Institute for Medical Research, Wynnewood, Pennsylvania

Requests for reprints: Christian Sell, Lankenau Medical Research Center, 100 E Lancaster Ave., Suite 176, Wynnewood, PA 19096. Phone: 610-645-8521; Fax: 610-645-2205; E-mail: sellc{at}mlhs.org.

Mutations in the three closely related RAS genes, HRAS, KRAS, and NRAS are among the most common mutations found in human cancer; reaching 50% in some types of cancer, such as colorectal carcinoma, and 10% in prostate cancers. The activated Ras proteins produced by these mutations can, among other cellular changes, increase vascular endothelial growth factor (VEGF) production. Moreover, tumors bearing RAS gene mutations are more vascular than tumors without RAS mutations. We find that, in prostate epithelial cells, the introduction of an activated HRAS causes cells to produce VEGF in response to insulin-like growth factor I (IGF-I). In comparison, cells lacking an activated Ras are unable to produce VEGF in response to IGF-I. This effect of Ras may occur through stabilization of a second messenger protein, insulin receptor substrate 1, that mediates PI 3-kinase-dependent signaling. Because IGF-I is a paracrine/endocrine hormone that has been associated with increased risk for several types of cancer, these results suggest a novel interrelationship between oncogenic conversion of a cellular gene such as HRAS, and IGF-I produced locally for normal tissue homeostasis.

Key Words: IGF-I • VEGF • Ras • angiogenesis • Genitourinary cancers: prostate • Tumor promotion and progression • Cell signaling • Angiogenesis and Microcirculation

This article has been cited by other articles:

				T. R. Graham, H. E. Zhau, V. A. Odero-Marah, A. O. Osunkoya, K. S. Kimbro, M. Tighiouart, T. Liu, J. W. Simons, and R. M. O'Regan Insulin-like Growth Factor-I-Dependent Up-regulation of ZEB1 Drives Epithelial-to-Mesenchymal Transition in Human Prostate Cancer Cells Cancer Res., April 1, 2008; 68(7): 2479 - 2488. [Abstract] [Full Text] [PDF]

				S. Cowey and R. W. Hardy The Metabolic Syndrome: A High-Risk State for Cancer? Am. J. Pathol., November 1, 2006; 169(5): 1505 - 1522. [Abstract] [Full Text] [PDF]